You are here

Article Text

Article menu
Download PDFPDF
Therapeutics
Randomised controlled trial
Should metformin be preferred over insulin therapy in the management of gestational diabetes (GDM)?
  1. Shannon D Sullivan
  1. Department of Endocrinology & Metabolism, Medstar Washington Hospital Center, Washington, DC, USA
  1. Correspondence to Dr Shannon D Sullivan
    Department of Endocrinology & Metabolism, Medstar Washington Hospital Center, 110 Irving Street, NW Suite 2A-72, Washington, DC, 20010, USA; Shannon.D.Sullivan{at}Medstar.net

https://doi.org/10.1136/eb-2013-101329

Statistics from Altmetric.com

    Request Permissions

    If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.

    Commentary on: Barrett HL, Gatford KL, Houda CM, et al. Maternal and neonatal circulating markers of metabolic and cardiovascular risk in the Metformin in Gestational Diabetes (MIG) trial: Responses to maternal metformin versus insulin treatment. Diabetes Care 2013;36:529–36.OpenUrlAbstract/FREE Full Text

    Context

    In this ancillary study of the Metformin in Gestational Diabetes (MiG) Trial, a prospective, randomised, multicentre trial in New Zealand and Australia, the investigators compare several circulating markers of metabolic risk in women with gestational diabetes (GDM) and in the cord blood of their offspring, to determine the differences between those treated with metformin or insulin during pregnancy.

    Methods

    In 236 metformin-treated and 242 insulin-treated women, fasting glucose, lipids, triglycerides (TGs), high-density lipoprotein, low-density lipoprotein and C reactive protein (CRP) were measured at randomisation (20–33 weeks’ gestation), at 36 weeks and at 6–8 weeks postpartum, as well as in cord blood. Treatment-group differences …

    View Full Text

    Footnotes

    • Competing interests None.